Young E. Whang
Impact in
- Oncology top 1%
- Viral-associated cancers and disorders
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 45
- Prostate Cancer Diagnosis and Treatment 9
- Renal cell carcinoma treatment 7
-
- PI3K/AKT/mTOR signaling in cancer 18
- Co-authors
- Charles L. Sawyers (8 shared papers)Xinyi Wu (4 shared papers)Elliott Kieff (4 shared papers)H. Shelton Earp (11 shared papers)Mehran S. Neshat (1 shared paper)James L. Mohler (6 shared papers)Jerome E. Tanner (2 shared papers)Xiu‐Juan Yuan (4 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Proceedings of the National Academy of Sciences (6 papers)Urologic Oncology Seminars and Original Investigations (6 papers)Gynecologic Oncology (4 papers)Oncogene (4 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Young E. Whang
95 papers receiving 5.5k citations
Young E. Whang's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.7k
- Cancer Research 874
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 3.2k
- Hematology 332
Countries citing papers authored by Young E. Whang
This map shows the geographic impact of Young E. Whang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young E. Whang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young E. Whang more than expected).
Fields of papers citing papers by Young E. Whang
This network shows the impact of papers produced by Young E. Whang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young E. Whang. The network helps show where Young E. Whang may publish in the future.
Co-authors
The 25 scholars most cited alongside Young E. Whang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway Hit paper breakdown → | 1998 | 539 |
| 2 | Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Hit paper breakdown → | 1998 | 526 |
| 3 | 1987 | 408 | |
| 4 | 2000 | 327 | |
| 5 | 2007 | 197 | |
| 6 | 1996 | 191 | |
| 7 | 2005 | 176 | |
| 8 | 2010 | 143 | |
| 9 | 2003 | 131 | |
| 10 | 2000 | 118 | |
| 11 | 2006 | 114 | |
| 12 | 2005 | 107 | |
| 13 | 2002 | 107 | |
| 14 | 1990 | 107 | |
| 15 | 1988 | 107 | |
| 16 | 2002 | 100 | |
| 17 | 2002 | 94 | |
| 18 | 2017 | 93 | |
| 19 | 2021 | 93 | |
| 20 | 2009 | 86 |
About Young E. Whang
Young E. Whang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 101 papers that have together received 5.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (45 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (874 citations), Pulmonary and Respiratory Medicine (1.5k citations), Molecular Biology (3.2k citations) and Hematology (332 citations). Young E. Whang has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Charles L. Sawyers, Xinyi Wu, Elliott Kieff, H. Shelton Earp, Mehran S. Neshat, James L. Mohler, Jerome E. Tanner, Xiu‐Juan Yuan, Douglas T. Fearon and Janis J. Weis. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Urologic Oncology Seminars and Original Investigations, Gynecologic Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.